100 “super encouraging” signs of recovery
L1 Capital’s founders tapped the collective wisdom of virologists from around the world in pandemic-proofing their portfolio. CIOs Mark Landau and Raphael Lamm have held around 100 meetings with vaccine specialists since COVID breached international borders last February.
“Today, our opinion on the vaccine is more nuanced than what many out there in the market might be talking about,” says Landau.
And while eyeballs are on Israel for other reasons right now, as conflict with Palestine sadly reignites, Landau and Lamm have been watching for other reasons since last November. “Israel is by far the best illustration of whether the vaccine is working globally,” Landau says.
In the following interview, Landau outlines three reasons for hope – even in the face of likely “mutant strains” – and why Australia’s response has lagged. This in turn affects L1’s preferred reopening plays, as discussed in the following video.
Видео 100 “super encouraging” signs of recovery канала Livewire Markets
“Today, our opinion on the vaccine is more nuanced than what many out there in the market might be talking about,” says Landau.
And while eyeballs are on Israel for other reasons right now, as conflict with Palestine sadly reignites, Landau and Lamm have been watching for other reasons since last November. “Israel is by far the best illustration of whether the vaccine is working globally,” Landau says.
In the following interview, Landau outlines three reasons for hope – even in the face of likely “mutant strains” – and why Australia’s response has lagged. This in turn affects L1’s preferred reopening plays, as discussed in the following video.
Видео 100 “super encouraging” signs of recovery канала Livewire Markets
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![A big shift in China and the implications for resources](https://i.ytimg.com/vi/-CO6HTwxqRU/default.jpg)
![Buy Hold Sell: 3 classic income stocks (and 2 with adviser approval)](https://i.ytimg.com/vi/7J4RvoyT97U/default.jpg)
![WAAAX: Buy Hold or Sell?](https://i.ytimg.com/vi/oP8I68Ogaq8/default.jpg)
![Why these fundies are still bullish on tech platforms](https://i.ytimg.com/vi/s8SRxzQpoxg/default.jpg)
![How Lazard's Philipp Hofflin uses 150 years of data to find the best ASX income stocks](https://i.ytimg.com/vi/to08QMT-UYs/default.jpg)
![Small caps are in a bear market: Here's what to do now](https://i.ytimg.com/vi/q_xSO1WkiA4/default.jpg)
![Buy Hold Sell: 3 of the ASX's most shorted stocks (and 2 long-term buys)](https://i.ytimg.com/vi/r3TOwvR9wwI/default.jpg)
![Buy Hold Sell - The top 5 of 2015](https://i.ytimg.com/vi/vUX66p5Nbug/default.jpg)
![Buy Hold Sell: 3 rockstars (and 2 past their prime)](https://i.ytimg.com/vi/iNbHmt0KG8A/default.jpg)
![Buy Hold Sell: 5 quality micro-caps](https://i.ytimg.com/vi/piLiLu_7b74/default.jpg)
![Buy Hold Sell: 5 stocks with a tourism tailwind](https://i.ytimg.com/vi/G9-5blFYvT4/default.jpg)
![Buy Hold Sell: Stocks for a stormy market](https://i.ytimg.com/vi/FwhOWI7afpU/default.jpg)
![What could derail equity markets?](https://i.ytimg.com/vi/iu0j4qKTdyg/default.jpg)
![Livewire Live Highlights 2017](https://i.ytimg.com/vi/j_CWtoVTdlA/default.jpg)
![Buy Hold Sell: 3 global giants and 2 due for a pullback](https://i.ytimg.com/vi/RVIGpDLBXB8/default.jpg)
![6 questions with Paul Skamvougeras](https://i.ytimg.com/vi/kwpkL5rI264/default.jpg)
![What’s changed in financial markets?](https://i.ytimg.com/vi/a3wOQvriSmw/default.jpg)
![Investing in tech without the nosebleed valuations](https://i.ytimg.com/vi/6tABfwqMycc/default.jpg)
![Signal or Noise: Will the Reserve Bank pause rate hikes in early 2023?](https://i.ytimg.com/vi/ZbPFgcdHHLU/default.jpg)
![Buy Hold Sell: 6 quality compounders for your back pocket](https://i.ytimg.com/vi/iP7zpVboR3w/default.jpg)